- Home
- OPRX
as 07-26-2024 4:00pm EST
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 183.1M | IPO Year: | N/A |
| Target Price: | $16.00 | AVG Volume (30 days): | 127.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.03 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.92 - $16.65 | Next Earning Date: | 08-08-2024 |
| Revenue: | $78,208,596 | Revenue Growth: | 26.71% |
| Revenue Growth (this year): | 44.71% | Revenue Growth (next year): | 11.40% |
Stock Insider Trading Activity of OptimizeRx Corporation (OPRX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Odence-Ford Marion | OPRX | General Counsel and CCO | Jan 9 '24 | Sell | $15.19 | 4,000 | $60,750.80 | 11,114 | SEC Form 4 |
Latest OptimizeRx Corporation News
OPRX Breaking Stock News: Dive into OPRX Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
GlobeNewswire
4 days ago
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
GlobeNewswire
12 days ago
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
Simply Wall St.
a month ago
OptimizeRx (NASDAQ:OPRX) shareholders have endured a 83% loss from investing in the stock three years ago
GlobeNewswire
a month ago
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
GOBankingRates
2 months ago
5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
AFP
2 months ago
Bumrah delivers as India beat Pakistan in low-scoring thriller
AFP
2 months ago
Italy beat Bosnia in final Euros warm-up
Compare OPRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OPRX OptimizeRx Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.